NIAID Awards EraGen Grant for Genomics-based Bioweapon Diagnostics | GenomeWeb

NEW YORK, Sept. 9 (GenomeWeb News) - EraGen Biosciences, a genetic diagnostics firm based in Madison, Wis., said today that the National Institute of Allergy and Infectious Diseases has awarded it a biodefense grant worth "nearly $1 million" to develop diagnostics for bioweapons detection using its GeneCode sample quantitation and genotyping system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.